FAKTORI POVEZANI SA IMUNIZACIJOM PROTIV SEZONSKOG GRIPA MEĐU OSOBAMA SA HRONIČNIM BOLESTIMA
Imunizacija u hroničnim bolestima
Ključne reči:
grip, imunizacija, hronične bolesti, prediktori
Sažetak
Svake godine od 3 do 5 miliona ljudi u svetu ima teške kliničke oblike gripa, a do 650.000 umire od komplikacija povezanih sa gripom. Osobe sa hroničnim bolestima, poput kardiovaskularnih, plućnih, bubrežnih, jetrenih, neuroloških, hematoloških, metaboličkih bolesti ili osoba koji primaju imunosupresivnu terapiju, predstavljaju rizičnu populacionu grupu za razvoj komplikacija povezanih sa gripom, teži klinički tok i lošije ishode osnovne bolesti. Zbog toga se osobe sa hroničnim bolestima smatraju prioritetnom populacijom za imunizaciju protiv gripa. Imunizacija predstavlja ključnu strategiju za sprečavanje gripa kako u pogledu obezbeđivanja imuniteta tako i u pogledu troškova zdravstvene zaštite. Na osnovu preporuka Svetske zdravstvene organizacije (SZO), odgovarajući obuhvat imunizacijom protiv gripa među osobama sa hroničnim bolestima predstavlja 75%. Međutim, malo zemalja dostiže ovaj prag obuhvata. Razumevanje prediktivnih faktora vakcinacije na različitim nivoima pružanja zdravstvene zaštite (kao što su pojedinci, zdravstveni radnici, zdravstvena politika) je od suštinskog značaja za obezbeđivanje adekvatnog imuniteta i postizanje preporučenog nivoa obuhvata vakcinacijom. U ovom mini preglednom radu sumirali smo naučne dokaze o obuhvatu vakcinacijom protiv gripa i faktore povezane sa imunizacije protiv gripa kod osoba sa hroničnim bolestima u celini, kao i u odnosu na određene bolesti kao što su: kardiovaskularne i plućne, dijabetes i maligne bolesti. Na osnovu pregledanih naučnih radova, utvrdili smo širok spektar faktora povezanih sa imunizacijom protiv gripa kod osoba sa hroničnim bolestima. Iako raznoliki, ovi faktori se mogu sistematizovati u 4 različite grupe: socio-demografske karakteristike, individualni stavovi i verovanja, ponašanja koja promovišu zdravlje i faktori povezani sa zdravstvenim sistemom. Potrebni je uložiti dalje napore da bi se poboljšao obuhvat vakcinacijom protiv gripa kod osoba sa hroničnim bolestima. Strategija imunizacije treba da uključi zdravstveni sistem i širu zajednicu kako bi podržali osobe sa hroničnim bolestima da se kontinuirano vakcinišu protiv gripa.
Reference
1. World Health Organization (WHO). Seasonal Influenza factsheet. Availbale at: http://www.who.int/mediacentre/factsheets/fs211/en/index.html Accessed on March 26, 2021
2. European Centre for Disease Prevention and Control. Seasonal influenza. Prevention Makes a Difference. Available at: https://www.ecdc.europa.eu/en/seasonal-influenza/facts/key-messages Accessed on March 26, 2021
3. Moghadami M. A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci. 2017;42(1):2-13.
4. Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16:47-60.
5. Buchy P, Badur S. Who and when to vaccinate against influenza. Int J Infect Dis.2020;93:375-87.
6. Cheng Y, Cao X, Cao Z, Xu C, Sun L, Gao Y, et al. Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality. Ageing Res Rev. 2020; 62:101124.
7. European Center for Disease Control and Prevention. Risk groups for severe influenza. Available from https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/risk-groups Accessed on April 10, 2021.
8. Arriola C, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, et al. Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza. Clin Infect Dis. 2017;65(8):1289-97.
9. Centers for Disease Control and Prevention. Seasonal Flu Shot. Available at: https://www.cdc.gov/flu/prevent/flushot.htm Accessed on April 10, 2021.
10. World Health Organization. Seasonal vaccination policies and coverage in the European Region. Available at: https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/seasonal-vaccination-policies-and-coverage-in-the-european-region Accessed on April 10, 2021.
11. Jorgensen P, Mereckieneb J, Cotterb S, Johansenc K, Tsolovac S, Browna C. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine. 2018;36(4):442-52.
12. Yan S, Wang Y, Zhu W, Zhang L, Gu H, Liu D, et al. Barriers to influenza vaccination among different populations in Shanghai. Hum Vaccin Immunother. 2020;1-9.
13. Papaioannou A, Konstantinidi A-E, Primikiri E, Asimakopoulou F, Aravantinos D, Mavromichali Z. Influenza vaccination rate among high risk group patients in primary health care in Greece. Cent Eur J Public Health. 2020;28(4):297-301.
14. Bertoldo G, Pesce A, Pepe A, Pelullo CP, Di Giuseppe G. Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy. PLoS One. 2019; 14(5).
15. Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine. 2011;29:3031-7.
16. Casalino E, Ghazali A, Bouzid D, Antoniol S, Pereira L, Kenway P, et al. Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake. PLoS One. 2018;13(3).
17. Bodeker B, Remschmidt C, Schmich P, Wichmann O. Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health. 2015;15:618.
18. Rodríguez-Rieiro C, Domínguez-Berjón MF, Esteban-Vasallodomínguez-Berjón MD, Cuadrado AR, Carrasco-Garrido P, Jiménez-García R. Coverage and predictors of influenza vaccine uptake among adults aged 16 to 59 years suffering from a chronic condition in Madrid, Spain. Hum Vaccin. 2011;7(5):557-62.
19. Quinn SC, Jamison AM, Freimuth VS, An J , Hancock GR. Determinants of influenza vaccination among high-risk Black and White adults. Vaccine. 2017;35(51):7154-9.
20. Borthwick C, O'Connor R, Kennedy L. Psychological predictors of seasonal influenza vaccination uptake among adults with a high-risk physical health condition: a systematic review. Psychol Health. 2021;36(2):214-35.
21. Pandolfi E, Marino MG, Carloni E, Romano M, Gesualdo F, Borgia P, et al. The effect of physician's recommendation on seasonal influenza immunization in children with chronic diseases. BMC Public Health. 2012;12:984.
22. Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, Gesualdo F, Romano M, et al. Immunization coverage and timeliness in Italian children with chronic diseases. Vaccine. 2012; 20(7):5172-8.
23. Daley MF, Beaty BL, Barrow J, Pearson K, Crane LA, Berman S, et al. Missed opportunities for influenza vaccination in children with chronic medical conditions. Arch Pediatr Adolesc Med. 2005;159:986-91.
24. Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013;99(24):1843-8.
25. Jiménez-García R, Hernández-Barrera V, de Andres AL, Jimenez-Trujillo I, Esteban J, Gil A, et al. Predictors of influenza vaccination uptake among adults with a history of heart attack. Hum Vaccin. 2010;6(7):566-71.
26. Turner S, J de Souza R, Kumareswaran R, Singh SM. Barriers to Influenza Vaccination in Patients with Implantable Cardiac Defibrillators. Can J Cardiovasc Nurs. Summer 2015;25(3):17-23.
27. Influenza infection and heart failure-vaccination may change heart failure prognosis? Kadoglou NPE, Bracke F, Simmers T, Tsiodras S, Parissis J. Heart Fail Rev. 2017;22(3):329-36.
28. Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, et al. Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial. JACC Heart Fail. 2016;4(2):152-8.
29. Olanipekun T, Effoe VS, Olanipekun O, Igbinomwanhia E, Kola-Kehinde O, Fotzeu C, et al. Factors influencing the uptake of influenza vaccination in African American patients with heart failure: Findings from a large urban public hospital. Heart Lung. 2020;49(3):233-7.
30. Bare I, Crawford J, Pon K, Farida N, Dehghani P. Frequency and Consequences of Influenza Vaccination in Adults With Congenital Heart Disease. Am J Cardiol. 2018;121(4):491-4.
31. López-de-Andrés A, Carrasco-Garrido P, Hernández-Barrera V, de Miguel AG, Jiménez-García R. Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain. Eur J Public Health. 2008;18(2):173-7.
32. Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, de Miguel AG. Predictors of influenza vaccination in adults with chronic bronchitis. Respir Med. 2009;103(10):1518-25.
33. Cheung KW, Mak YM. Association between Psychological Flexibility and Health Beliefs in the Uptake of Influenza Vaccination among People with Chronic Respiratory Diseases in Hong Kong. Int J Environ Res Public Health. 2016;13(2):155.
34. Santos-Sancho JM, Jimenez-Trujillo I, Hernández-Barrera V, López-de Andrés A, Carrasco-Garrido P, Ortega-Molina P, et al. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Hum Vaccin Immunother. 2012;8(7):938-45.
35. Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, Lopez de Andrés A, Miguel de Diez J, Gil de Miguel A. Coverage and predictors of adherence to influenza vaccination among Spanish children and adults with asthma. Infection. 2010;38(1):52-7.
36. Keenan H, Campbell J, Evans PH. Influenza vaccination in patients with asthma: why is the uptake so low? Br J Gen Pract. 2007;57(538):359-63.
37. Asciak R, Balzan M, Buttigieg J. Predictors of seasonal influenza vaccination in chronic asthma. Multidiscip Respir Med. 2013;8(1):68.
38. Lyn-Cook R, Halm EA, Wisnivesky JP. Determinants of adherence to influenza vaccination among inner-city adults with persistent asthma. Prim Care Respir J. 2007;16(4):229-35.
39. Ye L, Chen J, Fang T, Cui J, Li H, Ma R, et al. Determinants of healthcare workers’ willingness to recommend the seasonal influenza vaccine to diabetic patients: A cross-sectional survey in Ningbo, China. Hum Vaccin Immunother. 2018;14(12):2979-86.
40. Ko YM, Ko SH, Han K, Park Y-M, Choi JY, Kim SY, et al. Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study. Diabetes Metab J. 2021;45(1):55-66.
41. Jiménez-García R, Jimenez I, Garrido PC, Hernández-Barrera V, de Andres AL, del Barrio JL, et al. Coverage and predictors of influenza vaccination among adults with diabetes in Spain. Diabetes Res Clin Pract. 2008;79(3):510-7.
42. Olatunbosun OD, Esterhuizen TM, Wiysonge CS. A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa. Vaccine. 2017;35(47):6375-86.
43. Feng W, Cui J, Li H. Determinants of Willingness of Patients with Type 2 Diabetes Mellitus to Receive the Seasonal Influenza Vaccine in Southeast China. Int J Environ Res Public Health. 2019;16(12):2203
44. Alkan A, Karcı E, Yaşar A, Tuncay G, Köksoy EB, Ürün M, et al. Vaccination in oncology practice and predictors. Support Care Cancer. 2017;25(9):2677-82.
45. Kersun LS, Reilly AF, Coffin SE, Sullivan KE. Protecting Pediatric Oncology Patients From Influenza. Oncologist. 2013;18(2):204-11.
46. Kersun LS, Reilly A, Coffin SE, Boyer J, Luning Prak ET, McDonald K, et al. A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort. Influenza Other Respir Viruses. 2013;7(6):1158-67.
47. Oh MG, Han MA, Yun NR, Park J, Ryu SY, Kim DM, et al. A Population-Based, Nationwide Cross-Sectional Study on Influenza Vaccination Status among Cancer Survivors in Korea. Int J Environ Res Public Health. 2015;12(8):10133-49.
48. Poeppl W, Lagler H, Raderer M, Sperr WR, Zielinski C, Herkner H, et al. Influenza vaccination perception and coverage among patients with malignant disease. Vaccine. 2015;33(14):1682-7.
49. Vinograd I, Baslo R, Eliakim-Raz N, Farbman L, Taha A, Sakhnini A, et al. Factors associated with influenza vaccination among adult cancer patients: a case-control study. Clin Microbiol Infect. 2014;20(9):899-905.
50. Stafford KA, Sorkin JD, Steinberger EK. Influenza vaccination among cancer survivors: disparities in prevalence between blacks and whites. J Cancer Surviv. 2013;7(2):183-90.
2. European Centre for Disease Prevention and Control. Seasonal influenza. Prevention Makes a Difference. Available at: https://www.ecdc.europa.eu/en/seasonal-influenza/facts/key-messages Accessed on March 26, 2021
3. Moghadami M. A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci. 2017;42(1):2-13.
4. Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16:47-60.
5. Buchy P, Badur S. Who and when to vaccinate against influenza. Int J Infect Dis.2020;93:375-87.
6. Cheng Y, Cao X, Cao Z, Xu C, Sun L, Gao Y, et al. Effects of influenza vaccination on the risk of cardiovascular and respiratory diseases and all-cause mortality. Ageing Res Rev. 2020; 62:101124.
7. European Center for Disease Control and Prevention. Risk groups for severe influenza. Available from https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/risk-groups Accessed on April 10, 2021.
8. Arriola C, Garg S, Anderson EJ, Ryan PA, George A, Zansky SM, et al. Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza. Clin Infect Dis. 2017;65(8):1289-97.
9. Centers for Disease Control and Prevention. Seasonal Flu Shot. Available at: https://www.cdc.gov/flu/prevent/flushot.htm Accessed on April 10, 2021.
10. World Health Organization. Seasonal vaccination policies and coverage in the European Region. Available at: https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/seasonal-vaccination-policies-and-coverage-in-the-european-region Accessed on April 10, 2021.
11. Jorgensen P, Mereckieneb J, Cotterb S, Johansenc K, Tsolovac S, Browna C. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine. 2018;36(4):442-52.
12. Yan S, Wang Y, Zhu W, Zhang L, Gu H, Liu D, et al. Barriers to influenza vaccination among different populations in Shanghai. Hum Vaccin Immunother. 2020;1-9.
13. Papaioannou A, Konstantinidi A-E, Primikiri E, Asimakopoulou F, Aravantinos D, Mavromichali Z. Influenza vaccination rate among high risk group patients in primary health care in Greece. Cent Eur J Public Health. 2020;28(4):297-301.
14. Bertoldo G, Pesce A, Pepe A, Pelullo CP, Di Giuseppe G. Seasonal influenza: Knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy. PLoS One. 2019; 14(5).
15. Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine. 2011;29:3031-7.
16. Casalino E, Ghazali A, Bouzid D, Antoniol S, Pereira L, Kenway P, et al. Patient’s behaviors and missed opportunities for vaccination against seasonal epidemic influenza and evaluation of their impact on patient’s influenza vaccine uptake. PLoS One. 2018;13(3).
17. Bodeker B, Remschmidt C, Schmich P, Wichmann O. Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health. 2015;15:618.
18. Rodríguez-Rieiro C, Domínguez-Berjón MF, Esteban-Vasallodomínguez-Berjón MD, Cuadrado AR, Carrasco-Garrido P, Jiménez-García R. Coverage and predictors of influenza vaccine uptake among adults aged 16 to 59 years suffering from a chronic condition in Madrid, Spain. Hum Vaccin. 2011;7(5):557-62.
19. Quinn SC, Jamison AM, Freimuth VS, An J , Hancock GR. Determinants of influenza vaccination among high-risk Black and White adults. Vaccine. 2017;35(51):7154-9.
20. Borthwick C, O'Connor R, Kennedy L. Psychological predictors of seasonal influenza vaccination uptake among adults with a high-risk physical health condition: a systematic review. Psychol Health. 2021;36(2):214-35.
21. Pandolfi E, Marino MG, Carloni E, Romano M, Gesualdo F, Borgia P, et al. The effect of physician's recommendation on seasonal influenza immunization in children with chronic diseases. BMC Public Health. 2012;12:984.
22. Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, Gesualdo F, Romano M, et al. Immunization coverage and timeliness in Italian children with chronic diseases. Vaccine. 2012; 20(7):5172-8.
23. Daley MF, Beaty BL, Barrow J, Pearson K, Crane LA, Berman S, et al. Missed opportunities for influenza vaccination in children with chronic medical conditions. Arch Pediatr Adolesc Med. 2005;159:986-91.
24. Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart. 2013;99(24):1843-8.
25. Jiménez-García R, Hernández-Barrera V, de Andres AL, Jimenez-Trujillo I, Esteban J, Gil A, et al. Predictors of influenza vaccination uptake among adults with a history of heart attack. Hum Vaccin. 2010;6(7):566-71.
26. Turner S, J de Souza R, Kumareswaran R, Singh SM. Barriers to Influenza Vaccination in Patients with Implantable Cardiac Defibrillators. Can J Cardiovasc Nurs. Summer 2015;25(3):17-23.
27. Influenza infection and heart failure-vaccination may change heart failure prognosis? Kadoglou NPE, Bracke F, Simmers T, Tsiodras S, Parissis J. Heart Fail Rev. 2017;22(3):329-36.
28. Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, et al. Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF Trial. JACC Heart Fail. 2016;4(2):152-8.
29. Olanipekun T, Effoe VS, Olanipekun O, Igbinomwanhia E, Kola-Kehinde O, Fotzeu C, et al. Factors influencing the uptake of influenza vaccination in African American patients with heart failure: Findings from a large urban public hospital. Heart Lung. 2020;49(3):233-7.
30. Bare I, Crawford J, Pon K, Farida N, Dehghani P. Frequency and Consequences of Influenza Vaccination in Adults With Congenital Heart Disease. Am J Cardiol. 2018;121(4):491-4.
31. López-de-Andrés A, Carrasco-Garrido P, Hernández-Barrera V, de Miguel AG, Jiménez-García R. Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain. Eur J Public Health. 2008;18(2):173-7.
32. Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, López de Andrés A, de Miguel AG. Predictors of influenza vaccination in adults with chronic bronchitis. Respir Med. 2009;103(10):1518-25.
33. Cheung KW, Mak YM. Association between Psychological Flexibility and Health Beliefs in the Uptake of Influenza Vaccination among People with Chronic Respiratory Diseases in Hong Kong. Int J Environ Res Public Health. 2016;13(2):155.
34. Santos-Sancho JM, Jimenez-Trujillo I, Hernández-Barrera V, López-de Andrés A, Carrasco-Garrido P, Ortega-Molina P, et al. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Hum Vaccin Immunother. 2012;8(7):938-45.
35. Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, Lopez de Andrés A, Miguel de Diez J, Gil de Miguel A. Coverage and predictors of adherence to influenza vaccination among Spanish children and adults with asthma. Infection. 2010;38(1):52-7.
36. Keenan H, Campbell J, Evans PH. Influenza vaccination in patients with asthma: why is the uptake so low? Br J Gen Pract. 2007;57(538):359-63.
37. Asciak R, Balzan M, Buttigieg J. Predictors of seasonal influenza vaccination in chronic asthma. Multidiscip Respir Med. 2013;8(1):68.
38. Lyn-Cook R, Halm EA, Wisnivesky JP. Determinants of adherence to influenza vaccination among inner-city adults with persistent asthma. Prim Care Respir J. 2007;16(4):229-35.
39. Ye L, Chen J, Fang T, Cui J, Li H, Ma R, et al. Determinants of healthcare workers’ willingness to recommend the seasonal influenza vaccine to diabetic patients: A cross-sectional survey in Ningbo, China. Hum Vaccin Immunother. 2018;14(12):2979-86.
40. Ko YM, Ko SH, Han K, Park Y-M, Choi JY, Kim SY, et al. Importance of Awareness and Treatment for Diabetes in Influenza Vaccination Coverage of Diabetic Patients under 65 Years: A Population-Based Study. Diabetes Metab J. 2021;45(1):55-66.
41. Jiménez-García R, Jimenez I, Garrido PC, Hernández-Barrera V, de Andres AL, del Barrio JL, et al. Coverage and predictors of influenza vaccination among adults with diabetes in Spain. Diabetes Res Clin Pract. 2008;79(3):510-7.
42. Olatunbosun OD, Esterhuizen TM, Wiysonge CS. A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa. Vaccine. 2017;35(47):6375-86.
43. Feng W, Cui J, Li H. Determinants of Willingness of Patients with Type 2 Diabetes Mellitus to Receive the Seasonal Influenza Vaccine in Southeast China. Int J Environ Res Public Health. 2019;16(12):2203
44. Alkan A, Karcı E, Yaşar A, Tuncay G, Köksoy EB, Ürün M, et al. Vaccination in oncology practice and predictors. Support Care Cancer. 2017;25(9):2677-82.
45. Kersun LS, Reilly AF, Coffin SE, Sullivan KE. Protecting Pediatric Oncology Patients From Influenza. Oncologist. 2013;18(2):204-11.
46. Kersun LS, Reilly A, Coffin SE, Boyer J, Luning Prak ET, McDonald K, et al. A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort. Influenza Other Respir Viruses. 2013;7(6):1158-67.
47. Oh MG, Han MA, Yun NR, Park J, Ryu SY, Kim DM, et al. A Population-Based, Nationwide Cross-Sectional Study on Influenza Vaccination Status among Cancer Survivors in Korea. Int J Environ Res Public Health. 2015;12(8):10133-49.
48. Poeppl W, Lagler H, Raderer M, Sperr WR, Zielinski C, Herkner H, et al. Influenza vaccination perception and coverage among patients with malignant disease. Vaccine. 2015;33(14):1682-7.
49. Vinograd I, Baslo R, Eliakim-Raz N, Farbman L, Taha A, Sakhnini A, et al. Factors associated with influenza vaccination among adult cancer patients: a case-control study. Clin Microbiol Infect. 2014;20(9):899-905.
50. Stafford KA, Sorkin JD, Steinberger EK. Influenza vaccination among cancer survivors: disparities in prevalence between blacks and whites. J Cancer Surviv. 2013;7(2):183-90.
Objavljeno
2021/07/21
Broj časopisa
Rubrika
Mini pregledni članak